Cerebral Amyloid Angiopathy Clinical Trial
Official title:
The Relationship Between the Static and Dynamic Balance of the Body the Influence of Eyesight and Muscle Tension in the Cervical Spine in Cerebral Amyloid Angiopathy Patients - a Pilot Study
Verified date | October 2021 |
Source | Military Institute of Medicine, Poland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Cerebral Amyloid Angiopathy (CAA) is one form of disease of the small vessels of the brain and can cause frequent cerebral hemorrhages as well as other types of stroke. The aim of the research was to examine the balance of the body in patients after a stroke and to determine how the tension of selected muscles of the cervical spine changes under the conditions of statics and dynamics, depending on the visual control or its absence.
Status | Completed |
Enrollment | 16 |
Est. completion date | October 10, 2020 |
Est. primary completion date | June 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 55 Years to 90 Years |
Eligibility | Patients Inclusion Criteria:1) stroke in the course of CAA; 2) the functional state of the patients, which allows independent walking in a place and at a distance; 3) no severe deficits in communication, memory, or understanding what can impede proper measurement performance; Patients Exclusion Criteria: 1) cause of stroke other than CAA; 2) stroke up to seven weeks after the episode; 3) epilepsy; 4) lack of trunk stability; 5) lack of independent walking; 6) high or very low blood pressure, dizziness, malaise. Healthy Inclusion Criteria: 1) the control group consisted of healthy subjects with a stable trunk; 2) with independent walking. Healthy Exclusion Criteria: 1) a history of neurologic or musculoskeletal disorders such as stroke or brain injury or other conditions that could affect their ability to active movement the trunk and the legs; 2) pain, dizziness; 3) permanent use of orthopedic supplies; 4) severe deficits in communication, memory, or understanding what can impede proper measurement performance; 5) high or very low blood pressure, dizziness, malaise. |
Country | Name | City | State |
---|---|---|---|
Poland | Military Institute of Medicine | Warsaw | Masovian District |
Lead Sponsor | Collaborator |
---|---|
Anna Olczak |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | static balance | TESTING STABILITY OF ATTITUDE with the use of the Biodex SD balance platform. | up to 1 week | |
Primary | dynamic balance | FALL RISK TEST was assessed on the Biodex SD platform. | up to 1 week | |
Primary | Unterberga Test | The subjects performed 50 steps, once with their eyes open and then with their eyes closed. | up to 1 week | |
Primary | Sternocleidomastoid muscle tension | It was assessed on the Luna EMG | up to 1 week | |
Primary | Longus Colli muscle tension | It was assessed on the Luna EMG | up to 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05486897 -
Periventricular White Matter Hyperintensities in Cerebral Amyloid Angiopathy and Hypertensive Arteriopathy
|
||
Recruiting |
NCT03969732 -
Multimodal Biomarkers for Diagnosis and Prognosis in CAA
|
Phase 3 | |
Completed |
NCT03542656 -
Application of Amyloid PET in Cerebral Amyloid Angiopathy
|
Phase 3 | |
Recruiting |
NCT04604587 -
MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA
|
Phase 3 | |
Completed |
NCT05565144 -
Brain Hemorrhage and Functional Outcome in Stroke Patients With CAA Features on Pre-thrombolysis MRI Treated With Intravenous Thrombolysis (Thrombolysis in CAA) ( Thromb in CAA )
|
||
Active, not recruiting |
NCT03464344 -
Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.
|
N/A | |
Completed |
NCT03824197 -
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)
|
N/A | |
Recruiting |
NCT06393712 -
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
|
Phase 2 | |
Active, not recruiting |
NCT01856699 -
Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
|
N/A | |
Recruiting |
NCT06128824 -
High Frequency Imaging in Cerebral Amyloid Angiopathy
|
||
Completed |
NCT01821118 -
Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy
|
Phase 2 | |
Not yet recruiting |
NCT06421532 -
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy
|
Phase 2 | |
Completed |
NCT05394636 -
Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy
|
||
Recruiting |
NCT04204642 -
SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)
|
||
Recruiting |
NCT05207475 -
Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)
|
N/A | |
Recruiting |
NCT04757597 -
Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage
|
N/A | |
Not yet recruiting |
NCT02361411 -
Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
|
N/A | |
Not yet recruiting |
NCT04654026 -
the Safety and Efficacy of Antiplatelet Therapy in Patients of CAA
|
||
Completed |
NCT04825808 -
Detailed Clinical and MRI Characteristics in Primary Non-traumatic Convexity Subarachnoid Haemorrhage Elderly Patients.
|
||
Recruiting |
NCT05680389 -
Antibiotics Against Amyloid Angiopathy
|
Phase 1/Phase 2 |